--2025/Q1-- / 9.340M--
--2024/Q4-- / 8.904M--
Nov 7, 20242024/Q39.111M / 7.499M--
Aug 8, 20242024/Q26.957M / 18.249M--
May 9, 20242024/Q128.935M / 9.065M--
US Stock MarketDetailed Quotes
NTLA Intellia Therapeutics
- 14.300
- +0.500+3.62%
Close Nov 22 16:00 ET
- 14.310
- +0.010+0.07%
Post 20:02 ET
1.46BMarket Cap-2623P/E (TTM)
14.580High13.640Low2.41MVolume14.000Open13.800Pre Close34.34MTurnover2.40%Turnover RatioLossP/E (Static)101.85MShares34.87052wk High1.51P/B1.44BFloat Cap12.82052wk Low--Dividend TTM100.57MShs Float202.730Historical High--Div YieldTTM6.81%Amplitude9.180Historical Low14.249Avg Price1Lot Size
Intellia Therapeutics Key Stats
Intellia Therapeutics Q3 2024 Earnings Date
Currency：USDNov 7, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 7.50M | 9.11M | +1.61M |
| Beat Est. | -37.47% | -24.02% | +21.50% |
| EPS | -1.39 | -1.34 | +0.05 |
| Beat Est. | -0.38% | +2.90% | +3.26% |
Analyst Rating
Nov 24, 2024
Intellia Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 12 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Intellia Therapeutics Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
